
Paul Strouts
CEO of Life Sciences at Acacium Group; oversees Proclinical, R&D Partners, and DRA across 250 staff in 12 countries
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Jun 2, 2026
Season 9 | Ep32 Paul Strouts: When Growing Headcount Is a Strategy and When It Is Just a Cost
57:28
57:50
57:55
58:00
S
57:24Sean AndersonHOST
Yeah, what, how do you see the next couple of years in our industry? What do you think is gonna change?

Paul StroutsGUEST
Yeah, I do, and I, and I've listened to a few, few of your previous podcast and, um, yeah, and some, some people I, I would go as far as to say have been, been a little bit dismissive o-of AI, um, thinking it won't, it won't do too much and, you know, may-maybe it's a little bit an unnecessary noise at the moment.

Paul StroutsGUEST
I think it's already, uh, affecting the kind of the clinical trial process, for example.

Paul StroutsGUEST
So if we're gonna affect that, getting drugs to market quicker, it can certainly affect recruitment.

Paul StroutsGUEST
I think that, you know, we, we are doing lots of things at the moment, you know, within, within, within the case in life sciences, kind of got an in-house AI tool.
S
62:41Sean AndersonHOST
So my final question is, what are you aiming for? What's the goal for you? Where are you heading? What's the end game?